Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-134,000
Closed -$42.4M 5418
2024
Q3
$42.4M Hold
134,000
﹤0.01% 2572
2024
Q2
$50.1M Buy
+134,000
New +$45.2M ﹤0.01% 2407
2024
Q1
Sell
-395,000
Closed -$181M 5322
2023
Q4
$181M Buy
395,000
+65,500
+20% +$32.3M ﹤0.01% 1713
2023
Q3
$160M Buy
329,500
+184,500
+127% +$86.7M ﹤0.01% 1692
2023
Q2
$64.8M Buy
+145,000
New +$73M ﹤0.01% 2324
2023
Q1
Sell
-135,600
Closed -$69.5M 5629
2022
Q4
$69.5M Hold
135,600
﹤0.01% 2247
2022
Q3
$65.8M Buy
135,600
+80,900
+148% +$39.4M ﹤0.01% 2249
2022
Q2
$25.6M Buy
+54,700
New +$24.3M ﹤0.01% 2948
2014
Q3
Sell
-1,100
Closed -$140K 3175
2014
Q2
$140K Hold
1,100
﹤0.01% 1622
2014
Q1
$124K Buy
+1,100
New +$115K ﹤0.01% 1667

Other funds holding HUM

BlackRock's HUM Position: Q2 2026 in Review

BlackRock increased its Humana (HUM) stake by 2.1% in Q2 2026, buying an estimated $62.3M and bringing the position to 10,417,803 shares worth $4.14B. The position accounts for 0.06% of the portfolio, ranked #261.

BlackRock first reported a position in HUM in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.93B in Q2 2022. 925 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • BlackRock held 10,417,803 shares of Humana worth $4.14B as of Q2 2026.
  • BlackRock bought 218,748 Humana shares in Q2 2026, an estimated $62.3M.
  • Humana made up 0.06% of BlackRock's portfolio in Q2 2026, its #261 holding.
  • BlackRock first reported a position in Humana in Q2 2013 and has held it in 53 quarters since.
  • BlackRock's Humana position peaked at $5.93B in Q2 2022.
  • 925 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.